Latest McMaster University Stories
HAMILTON and MARKHAM, Ontario, Feb. 28, 2011 /PRNewswire/ -- IBM (NYSE: IBM) today announced that it is collaborating with McMaster University to improve the energy uses and supplies in its buildings campus-wide.
New findings from a McMaster University-led study of a drug recently identified to prevent stroke in patients with atrial fibrillation have been published in the high-impact New England Journal of Medicine (NEJM) today.
TORONTO, Nov. 29, 2010 /PRNewswire/ -- Toronto-based Internet marketing firm Think Basis Inc. is donating $7000 to McMaster University in Hamilton.
McMaster University and DynaMedâ„¢ Partner to Identify Practice-Changing Evidence Across Medical Disciplines Partnership Brings Together Two of the Best Systems for Monitoring High-Quality Medical Research to Impact Patient Care Ipswich, MA (Vocus) October 20, 2010 McMaster Universityâ€™s Health Information Research Unit and DynaMedâ„¢ from EBSCO Publishing have partnered to help physicians understand the scope of the medical research being published every day.
A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients initially treated with a blood thinner, fondaparinux.
New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.
A new study has shown that a similar degree of muscle building can be achieved by using lighter weights.
A commonplace electroencephalography (EEG) test may hold the key to predicting whether a person will respond to certain prescribed drugs, particularly those related to psychiatric conditions.
A new study by researchers at McMaster University shows overweight and obese women face greater risks of preterm births.
TORONTO, July 13 /PRNewswire-FirstCall/ - A technical collaboration announced today between Biosign Technologies Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.